97 related articles for article (PubMed ID: 30942197)
1. Low expression of pentraxin 3 and nuclear factor-like 2 implying a relatively longer overall survival time in gliomas.
Ke HH; Hueng DY; Tsai WC
Chin J Physiol; 2019; 62(1):35-43. PubMed ID: 30942197
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.
Tung JN; Ko CP; Yang SF; Cheng CW; Chen PN; Chang CY; Lin CL; Yang TF; Hsieh YH; Chen KC
J Neurooncol; 2016 Sep; 129(2):201-9. PubMed ID: 27278519
[TBL] [Abstract][Full Text] [Related]
5. Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas.
Zhao M; Xu H; Zhang B; Hong B; Yan W; Zhang J
Hum Pathol; 2015 Jun; 46(6):843-9. PubMed ID: 25841304
[TBL] [Abstract][Full Text] [Related]
6. The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.
Huang ZY; Hueng DY; Tsai WC
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):74-82. PubMed ID: 30664534
[TBL] [Abstract][Full Text] [Related]
7. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas.
Locatelli M; Ferrero S; Martinelli Boneschi F; Boiocchi L; Zavanone M; Maria Gaini S; Bello L; Valentino S; Barbati E; Nebuloni M; Mantovani A; Garlanda C
J Neuroimmunol; 2013 Jul; 260(1-2):99-106. PubMed ID: 23664694
[TBL] [Abstract][Full Text] [Related]
8. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
9. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
10. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin-3 expression in acute renal allograft rejection.
Imai N; Nishi S; Yoshita K; Ito Y; Osawa Y; Takahashi K; Nakagawa Y; Saito K; Takahashi K; Narita I
Clin Transplant; 2012 Jul; 26 Suppl 24():25-31. PubMed ID: 22747472
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
[TBL] [Abstract][Full Text] [Related]
15. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
Gatto M; Ghirardello A; Luisetto R; Bassi N; Fedrigo M; Valente M; Valentino S; Del Prete D; Punzi L; Doria A
J Autoimmun; 2016 Nov; 74():208-216. PubMed ID: 27405845
[TBL] [Abstract][Full Text] [Related]
16. Serum pentraxin 3 as a possible marker for mature cystic teratomas.
Ishida C; Iwase A; Osuka S; Goto M; Takikawa S; Nakamura T; Kotani T; Kikkawa F
Gynecol Endocrinol; 2016 Sep; 32(9):733-736. PubMed ID: 26965297
[TBL] [Abstract][Full Text] [Related]
17. Increased Plasma Levels of Pentraxin 3 Are Associated with Poor Prognosis of Colorectal Carcinoma Patients.
Zhang J; Wang TY; Niu XC
Tohoku J Exp Med; 2016 Sep; 240(1):39-46. PubMed ID: 27568661
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TELO2 decreases survival in human high-grade gliomas.
Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of Pentraxin 3 in diagnosing the severity and cardiovascular function of the children with sepsis].
Kang X; Zhu Y; Zhang X
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):592-8. PubMed ID: 26717657
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression.
Zheng H; Nong Z; Lu G
Med Sci Monit; 2015 Sep; 21():2893-9. PubMed ID: 26410168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
